Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined herbal mouthwash for minor oral aphthous lesions
IRCT20220522054957N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone in aphthosis (RAS) (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Size of lesion, Pain level and 1 more. Started Sep 2022; status: completed.
02
Drugs
triamcinolone
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on IRCT20220522054957N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220522054957N1.